{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:24:58Z","timestamp":1782368698316,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1067\/mjd.2001.113475","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:20:53Z","timestamp":1027556453000},"page":"814-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Oral dexamethasone pulse treatment for vitiligo"],"prefix":"10.1067","volume":"44","author":[{"given":"Sonja","family":"Radakovic-Fijan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"F\u00fcrnsinn-Friedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"H\u00f6nigsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Tanew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2001.113475_bib1","first-page":"945","article-title":"Hypomelanoses and hypermelanoses","author":"Mosher","year":"1999"},{"key":"10.1067\/mjd.2001.113475_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","article-title":"Vitiligo","volume":"38","author":"Kovacs","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0733-8635(18)30279-1","article-title":"Management of vitiligo","volume":"11","author":"Nordlund","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2001.113475_bib4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archderm.1976.01630350007002","article-title":"Photochemotherapy of vitiligo","volume":"112","author":"Parrish","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0190-9622(82)70159-8","article-title":"Determination of optimal topical photochemotherapy for vitiligo","volume":"7","author":"Grimes","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib6","first-page":"165","article-title":"Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5\u2032,8-trimethylpsoralen, and psoralen in vitiligo","volume":"66","author":"Pathak","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1067\/mjd.2001.113475_bib7","first-page":"170","article-title":"Treatment of vitiligo with oral methoxsalen and UVA","volume":"1","author":"Lassus","year":"1984","journal-title":"Photodermatology"},{"key":"10.1067\/mjd.2001.113475_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(88)70092-4","article-title":"Treatment of vitiligo with khellin and ultraviolet A","volume":"18","author":"Ortel","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib9","first-page":"469","article-title":"PUVA-therapy and association of phenylalanine and UVA-therapy in vitiligo: a multicenter-study of 81 observations","volume":"2","author":"Pruvot-Sentous","year":"1992","journal-title":"Eur J Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0738-081X(97)00133-8","article-title":"Psoralen photochemotherapy","volume":"15","author":"Grimes","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib11","first-page":"1022","article-title":"Phototherapie mit UV-B bei Vitiligo","volume":"65","author":"K\u00f6ster","year":"1990","journal-title":"Z Hautkr"},{"key":"10.1067\/mjd.2001.113475_bib12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A","volume":"133","author":"Westerhof","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band UVB (TL 01) radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000246705","article-title":"Oral minipulse therapy in vitiligo","volume":"190","author":"Kanwar","year":"1995","journal-title":"Dermalology"},{"key":"10.1067\/mjd.2001.113475_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000252478","article-title":"Vitiligo-response to 0.2 percent betamethasone 17-valerate in flexible collodion","volume":"141","author":"Kandil","year":"1970","journal-title":"Dermatologica"},{"key":"10.1067\/mjd.2001.113475_bib17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2133.1977.tb15180.x","article-title":"Vitiligo: a new classification and therapy","volume":"97","author":"Koga","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archderm.1984.01650410073019","article-title":"Vitiligo treated with topical clobetasol proprionate","volume":"120","author":"Kumari","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-4362.1992.tb03559.x","article-title":"Nonpsoralen treatment of vitiligo. Part I. Cosmetics, systemic coloring agents, and corticosteroids","volume":"31","author":"Goldstein","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib20","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/archderm.134.12.1532","article-title":"Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature","volume":"134","author":"Njoo","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000252552","article-title":"Treatment of localized vitiligo with intradermal injections of triamcinolone acetonide","volume":"140","author":"Kandil","year":"1970","journal-title":"Dermatologica"},{"key":"10.1067\/mjd.2001.113475_bib22","first-page":"308","article-title":"Vitiligo and intralesional steroids","volume":"69","author":"Vasistha","year":"1979","journal-title":"Indian J Med Res"},{"key":"10.1067\/mjd.2001.113475_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000251114","article-title":"Treatment of vitiligo with oral corticosteroids","volume":"153","author":"Imamura","year":"1976","journal-title":"Dermatologica"},{"key":"10.1067\/mjd.2001.113475_bib24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0140-6736(78)92812-X","article-title":"Vitiligo and steroids","volume":"2","author":"Brostoff","year":"1978","journal-title":"Lancet"},{"key":"10.1067\/mjd.2001.113475_bib25","first-page":"464","article-title":"Prednisolone causing amelioration of both vitiligo and chronic active hepatitis","volume":"38","author":"Thomas","year":"1987","journal-title":"Br J Hosp Med"},{"key":"10.1067\/mjd.2001.113475_bib26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0733-8635(18)30271-7","article-title":"Vitiligo: an overview of therapeutic approaches","volume":"11","author":"Grimes","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2001.113475_bib28","first-page":"474","article-title":"A clinical trial of clobetasol propionate in Filipino vitiligo patients","volume":"9","author":"Geraldez","year":"1987","journal-title":"Clin Ther"},{"key":"10.1067\/mjd.2001.113475_bib29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0190-9622(94)70240-3","article-title":"Photochemotherapy beyond psoriasis","volume":"31","author":"Honig","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.113475_bib30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.135.9.1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201799367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201799367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:26:41Z","timestamp":1759267601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962201799367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0190962201799367"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2001.113475","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral dexamethasone pulse treatment for vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2001.113475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}